Squarepoint’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-85,504
Closed -$109K 3746
2021
Q4
$109K Buy
+85,504
New +$153K ﹤0.01% 2898
2021
Q3
Sell
-93,906
Closed -$352K 3612
2021
Q2
$352K Sell
93,906
-14,206
-13% -$49.4K ﹤0.01% 2408
2021
Q1
$352K Buy
108,112
+59,040
+120% +$212K ﹤0.01% 2283
2020
Q4
$167K Buy
49,072
+20,378
+71% +$83.9K ﹤0.01% 2578
2020
Q3
$117K Sell
28,694
-79,271
-73% -$301K ﹤0.01% 2253
2020
Q2
$365K Buy
+107,965
New +$315K 0.01% 1478
2020
Q1
Sell
-98,341
Closed -$358K 2704
2019
Q4
$358K Sell
98,341
-27,507
-22% -$222K ﹤0.01% 1946
2019
Q3
$1.04M Buy
125,848
+95,011
+308% +$769K 0.01% 1208
2019
Q2
$266K Sell
30,837
-28,588
-48% -$256K ﹤0.01% 1970
2019
Q1
$635K Buy
59,425
+37,799
+175% +$405K 0.01% 1359
2018
Q4
$189K Sell
21,626
-122,710
-85% -$1.56M ﹤0.01% 1701
2018
Q3
$2.42M Buy
144,336
+45,829
+47% +$992K 0.03% 650
2018
Q2
$2.06M Buy
+98,507
New +$1.82M 0.03% 612
2018
Q1
Sell
-76,983
Closed -$1.46M 2274
2017
Q4
$1.46M Sell
76,983
-10,493
-12% -$190K 0.03% 664
2017
Q3
$1.23M Buy
+87,476
New +$791K 0.02% 661
2017
Q1
Sell
-13,375
Closed -$59K 2004
2016
Q4
$59K Buy
+13,375
New +$56.1K ﹤0.01% 1691
2016
Q3
Sell
-13,447
Closed -$88K 1326
2016
Q2
$88K Buy
+13,447
New +$95K 0.01% 990
2016
Q1
Sell
-45,446
Closed -$274K 1513
2015
Q4
$274K Buy
+45,446
New +$260K 0.03% 839

Other funds holding SPPI

Squarepoint's SPPI Position: Q1 2022 in Review

Squarepoint sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 85,504 shares — an estimated $109K sold.

Squarepoint first reported a position in SPPI in Q4 2015 and held it in 18 quarters. The position peaked at $2.42M in Q3 2018. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Squarepoint reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Squarepoint sold 85,504 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $109K.
  • Squarepoint first reported a position in Spectrum Pharmaceuticals Inc in Q4 2015 and held it in 18 quarters.
  • Squarepoint's Spectrum Pharmaceuticals Inc position peaked at $2.42M in Q3 2018.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.